CRH Medical Corporation Common Shares of Beneficial Interest (CRHM) Social Stream



CRH Medical Corporation Common Shares of Beneficial Interest (CRHM): $3.99

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add CRHM to Watchlist
Sign Up

Industry: Medical - Services

Industry

NR

Ranked

#39 of 80

in industry

CRH Medical Corp (CRHM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CRHM.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $4 $3.23 $3.61 $3.99 -9.52%

CRHM reports an average of 38.33% for its upside potential over the past 170 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-11-13 5 4.0 3.23 3.61 2.47 46.15%
2020-10-25 5 4.0 3.20 3.50 2.20 59.09%
2020-09-10 5 4.0 3.20 3.50 2.28 53.51%
2020-08-21 6 4.0 3.00 3.41 2.47 38.06%
2020-08-11 7 4.0 2.00 3.21 2.55 25.88%
2020-08-02 7 3.5 2.00 2.87 2.34 22.65%
2020-07-15 7 3.5 2.00 2.87 2.33 23.18%
2020-06-25 7 3.5 2.00 2.87 2.16 32.87%
2020-05-27 7 3.0 2.00 2.80 1.95 43.59%

CRHM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The average analyst price target of CRHM is greater than 5.27% of all US stocks.
  • CRH Medical Corp's upside potential (average analyst target price relative to current price) is greater than 5.87% of Healthcare stocks.
  • CRHM has a less variance in analysts' estimates than 68.62% of Healthcare stocks.
  • CRHM has a greater number of analysts covering the stock than 68.02% of stocks in the small market cap category.

Make investment decisions regarding CRHM using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!